dc.contributor.author | Farrugia, AJ | |
dc.contributor.author | Calvo, F | |
dc.date.accessioned | 2016-11-24T14:02:04Z | |
dc.date.issued | 2016-12-15 | |
dc.identifier.citation | Biochemical Society transactions, 2016, 44 (6), pp. 1709 - 1716 | |
dc.identifier.issn | 0300-5127 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/284 | |
dc.identifier.eissn | 1470-8752 | |
dc.identifier.doi | 10.1042/bst20160219 | |
dc.description.abstract | Despite being discovered more than 15 years ago, the Borg (binder of Rho GTPases) family of Cdc42 effector proteins (Cdc42EP1-5) remains largely uncharacterised and relatively little is known about their structure, regulation and role in development and disease. Recent studies are starting to unravel some of the key functional and mechanistic aspects of the Borg proteins, including their role in cytoskeletal remodelling and signalling. In addition, the participation of Borg proteins in important cellular processes such as cell shape, directed migration and differentiation is slowly emerging, directly linking Borgs with important physiological and pathological processes such as angiogenesis, neurotransmission and cancer-associated desmoplasia. Here, we review some of these findings and discuss future prospects. | |
dc.format | Print | |
dc.format.extent | 1709 - 1716 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | PORTLAND PRESS LTD | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Cytoskeleton | |
dc.subject | Humans | |
dc.subject | rho GTP-Binding Proteins | |
dc.subject | Adaptor Proteins, Signal Transducing | |
dc.subject | GTP-Binding Protein Regulators | |
dc.subject | RNA-Binding Proteins | |
dc.subject | Cytoskeletal Proteins | |
dc.subject | Signal Transduction | |
dc.subject | Multigene Family | |
dc.subject | Models, Biological | |
dc.title | The Borg family of Cdc42 effector proteins Cdc42EP1-5. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2016-09-19 | |
rioxxterms.versionofrecord | 10.1042/bst20160219 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2016-12 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Biochemical Society transactions | |
pubs.issue | 6 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Tumour Microenvironment | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Tumour Microenvironment | |
pubs.publication-status | Published | |
pubs.volume | 44 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Tumour Microenvironment | |
dc.contributor.icrauthor | Farrugia, Aaron | |